News From Dr. Peter McCullough MD, Page 88
Beer et al, PLOS 2019, zero monkeypox deaths in US and elsewhere where there is contemporary management. In US we have…
Dr. Peter McCullough MD - Jul 19th 2022 3:54pm EDTBeer et al, PLOS 2019, zero monkeypox deaths in US and elsewhere where there is contemporary management. In US we have both PO and IV tecovirimat with a good performance profile. No need for alarm or ring inoculation strategy with Jynneos product. Easily treat rare US cases. 5/24/22
Getting ahead of wide usage on safety, Jynneos smallpox/monkeypox live attenuated caused 18% + troponin; in this case he…
Dr. Peter McCullough MD - Jul 19th 2022 3:52pm EDTGetting ahead of wide usage on safety, Jynneos smallpox/monkeypox live attenuated caused 18% + troponin; in this case heart damage did not resolve on followup MRI. Targets for “ring inoculation” after pox exposure should be clearly informed of heart damage with these products. 5/24/22
Simpson et al, Chatham House, London, monkeypox conference in 2019 summarizes 40 years of data on this established zoono…
Dr. Peter McCullough MD - Jul 19th 2022 3:38pm EDTSimpson et al, Chatham House, London, monkeypox conference in 2019 summarizes 40 years of data on this established zoonosis. Prior smallpox program protective for those age 50 and older in general. Cases mainly in young men. Mortality low except in advanced concurrent HIV. 5/23/22
Russo et al, 2021, tecovirimat review. Broad efficacy against family of orthopox viruses including monkeypox. Mentions…
Dr. Peter McCullough MD - Jul 19th 2022 3:36pm EDTRusso et al, 2021, tecovirimat review. Broad efficacy against family of orthopox viruses including monkeypox. Mentions future intravenous (recently approved) and pediatric applications. Good to see foundation for early therapy–should be first convo in public health response. 5/23/22
Rao et al, MMWR, Monkeypox case in Dallas Jul 2021 treated with tecovirimat. Extensive case contract tracing no spread….
Dr. Peter McCullough MD - Jul 19th 2022 3:32pm EDTRao et al, MMWR, Monkeypox case in Dallas Jul 2021 treated with tecovirimat. Extensive case contract tracing no spread. Publication just released a few weeks ago by CDC. First clinical question should be about therapy of the index case not about population based immunization. 5/23/22
Great to team up with Drs. Gkioulekas and Zelenko to demonstrate mathematical power of risk stratification in how doctor…
Dr. Peter McCullough MD - Jul 19th 2022 3:19pm EDTGreat to team up with Drs. Gkioulekas and Zelenko to demonstrate mathematical power of risk stratification in how doctors select patients for a range of intensive protocols in early treatment to save lives. Vast majority of hospitalizations and deaths were always avoidable. 5/17/22
No pro-V rallies, no ballrooms filled with celebrations over the genetic innovation, just more gloom as the administrati…
Dr. Peter McCullough MD - Jul 19th 2022 3:18pm EDTNo pro-V rallies, no ballrooms filled with celebrations over the genetic innovation, just more gloom as the administrations pile up every six months interspersed with breakthrough infections. Blood clots, heart damage, myriad of side effects sapping any remaining enthusiasm. 5/16/22
Brodin and Arditi, Lancet, analysis consistent with my original report on pediatric hepatitis is set up by GI SARS-CoV-2…
Dr. Peter McCullough MD - Jul 19th 2022 3:17pm EDTBrodin and Arditi, Lancet, analysis consistent with my original report on pediatric hepatitis is set up by GI SARS-CoV-2 and then superimposed adenovirus-41 otherwise not pathogenic. Explains world-wide nature of outbreak not linked to common food/water sources. 5/14/22
State of Tennessee HB 1982 Passed and officially recognizes natural protection from the respiratory illness giving full…
Dr. Peter McCullough MD - Jul 19th 2022 2:46pm EDTState of Tennessee HB 1982 Passed and officially recognizes natural protection from the respiratory illness giving full rights and privileges. Great relief for those who have survived the illness and were facing the unwanted mandated products. Great relief–go mass exemption! 5/5/22
Ontario mass program fails. Canadians must feel burned by the administration and performance of the big public health p…
Dr. Peter McCullough MD - Jul 19th 2022 2:45pm EDTOntario mass program fails. Canadians must feel burned by the administration and performance of the big public health push that turned lives upside down. Now the long repair phase of sorting through failures and injuries will take months to years. 5/5/22
Lind et al, Yale Univ, boosters fail against Omicron. Most studies intentionally ignore prior infection status, this on…
Dr. Peter McCullough MD - Jul 19th 2022 2:41pm EDTLind et al, Yale Univ, boosters fail against Omicron. Most studies intentionally ignore prior infection status, this one didn’t! VE
CDC/FDA never held regular safety briefings. “Just get V’d” and “Safe and Effective” slogans unacceptable without showi…
Dr. Peter McCullough MD - Jul 19th 2022 12:33pm EDTCDC/FDA never held regular safety briefings. “Just get V’d” and “Safe and Effective” slogans unacceptable without showing us the data. No long term safety assurances once the long-lasting genetic code is inserted into the body. Truth now coming out! 4/30/22
Many took genetic code before understanding that the Spike protein generated by the long lasting sequence drives both at…
Dr. Peter McCullough MD - Jul 19th 2022 12:26pm EDTMany took genetic code before understanding that the Spike protein generated by the long lasting sequence drives both atherosclerotic CVD events as well as fatal or near-fatal myocarditis prompting 911 calls. Israel served as the world’s test case for what was about to happen. 4/30/22
Myocarditis cardiac arrest strongly temporally related to 2nd dose. Epidemiology shows “waves of suspected cases” in yo…
Dr. Peter McCullough MD - Jul 19th 2022 12:24pm EDTMyocarditis cardiac arrest strongly temporally related to 2nd dose. Epidemiology shows “waves of suspected cases” in young persons that could coincide with mandate-induced surges. Every case needs administration record and clinical details: cTNI/T, ECG, echo, MRI, angiogram. 4/29/22
Vencati et al, VITT deaths can be months after injection. Histopathology of fatal embolic events similar. Anti-PF4 ant…
Dr. Peter McCullough MD - Jul 19th 2022 12:19pm EDTVencati et al, VITT deaths can be months after injection. Histopathology of fatal embolic events similar. Anti-PF4 antibody assessment is key to the pathological examination. Big question is what proportion of the large number of deaths afterwards is VITT/VTE causal pathway. 4/27/22
Peters et al, dangerous practice–novel genetic product with myocarditis warnings. No accounting for safety censoring o…
Dr. Peter McCullough MD - Jul 19th 2022 12:18pm EDTPeters et al, dangerous practice–novel genetic product with myocarditis warnings. No accounting for safety censoring or prior infection. Cleaner group is infection naive+boosted showing no effect. Need to always report safety and prior infection/recovered status every paper. 4/27/22
Marsh et al, 13 hospitalized pediatric hepatitis cases, one to transplant, 5 of them have pandemic virus exposure by hx,…
Dr. Peter McCullough MD - Jul 19th 2022 12:17pm EDTMarsh et al, 13 hospitalized pediatric hepatitis cases, one to transplant, 5 of them have pandemic virus exposure by hx, serology/Vx not reported. Hx of prior viral infection may set up liver inflammation by second hit with other viruses (rhino, sapo, entero, parainf, adeno etc). 4/26/22. @PeterMcCulloughMDwww.PeterMcCulloughMD.com
Tartoff et al, Kaiser, PFE-funded, majority (54%) hospital encounters 2- or 3-dose patients. Low VE across board, parti…
Dr. Peter McCullough MD - Jul 19th 2022 10:31am EDTTartoff et al, Kaiser, PFE-funded, majority (54%) hospital encounters 2- or 3-dose patients. Low VE across board, particularly weak for seniors needing most protection. No exclusion for prior infection/recovered and no mention of early treatment or death. 4/26/22
Genetic agent toxicity unrivaled among medications/products used in internal medicine. Victim was 52 year old male with…
Dr. Peter McCullough MD - Jul 19th 2022 10:30am EDTGenetic agent toxicity unrivaled among medications/products used in internal medicine. Victim was 52 year old male with induced auto-immune hepatitis. Concern now for those with baseline liver disease including NAFLD and hepatitis C. Both highly prevalent among those forced. 4/25/22
In safety analyses, temporal relationship is strong criteria for causality. Pattern strongly suggests the administered…
Dr. Peter McCullough MD - Jul 19th 2022 10:28am EDTIn safety analyses, temporal relationship is strong criteria for causality. Pattern strongly suggests the administered medical product caused the fatal event. Public understands readily. Baseline healthy, reluctantly takes mandated product–and then boom its over. 4/25/22
Dr. Kulldorff, Brownstone summary of trial data showing clear advantage for adenoviral compared to the other genetic pro…
Dr. Peter McCullough MD - Jul 19th 2022 10:19am EDTDr. Kulldorff, Brownstone summary of trial data showing clear advantage for adenoviral compared to the other genetic products. Selection bias for overall study population + other explanations are possible but large difference in effect sizes must be examined. 4/23/22
Mass formation, guilt, lack of outrage, physician denial of causation, all converging to leave VICP lifeless. Dr. Dema…
Dr. Peter McCullough MD - Jul 19th 2022 10:18am EDTMass formation, guilt, lack of outrage, physician denial of causation, all converging to leave VICP lifeless. Dr. Demasi, BMJ exposes failed program despite large numbers of deaths, disabilities, and serious organ injury syndromes warranting hospitalization, UC, or office care. 4/20/22
Follmann et al, RCT, biologicals impair immune response on breakthrough infection. Reduced viral copies may represent a…
Dr. Peter McCullough MD - Jul 19th 2022 10:17am EDTFollmann et al, RCT, biologicals impair immune response on breakthrough infection. Reduced viral copies may represent anti-S effect, however works for lesser overall strength of antibody response when challenged with virus. May have implications for future V-resistant variants. 4/20/22
Dr. McCullough with pediatrician Dr. Paul Thomas. Its a disaster for each person who takes one.
Dr. Peter McCullough MD - Jul 19th 2022 7:37am EDTDr. McCullough with pediatrician Dr. Paul Thomas. Its a disaster for each person who takes one.
https://twitter.com/p_mcculloughmd/status/1548790996850200576?s=21&t=APKMI7Sl18KENsKEqOoOOw
Dr. Peter McCullough MD - Jul 18th 2022 4:41pm EDThttps://twitter.com/p_mcculloughmd/status/1548790996850200576?s=21&t=APKMI7Sl18KENsKEqOoOOw Twitter MTAs can take weeks to months for university research and NIH legal departments to prepare and sign. This UNC-MDRN MTA clearly shows they were far along on the product long before virus emerged into the population and started its deadly run. MDRN NIH UNC…